Sina Mehr Fajr Mazandaran Company
deals with research and development, production and commercialization of knowledge-based products and services in the field of health and medicine. The focus of the activities of this company is on advanced medical technologies, including biotechnology, nanotechnology, regenerative medicine (cell therapy and tissue engineering), and information technology (software, hardware, and artificial intelligence) in the applications of prevention, diagnosis, treatment, care and rehabilitation. The nature of these products can be biological products, medical devices, drugs, supplements, cosmetics and personal care products, or even foods.

Our Products and Services:
Intelligentization of medical diagnostic laboratories
It is a platform consisting of hardware and software for online management of equipment and utilities of medical diagnosis laboratories in order to monitor, record and control of electrical parameters as well as temperature and humidity of the environment and refrigerators with the aim of ensuring correct operation and protection of equipment and reducing energy consumption.
Newborn metabolic diseases screening test
This test is performed in order to screen 22 hereditary metabolic diseases, which are mainly caused by genetic defects in babies. It is conducted at the birth of the babies with only one sampling and using the advanced technique of LC Mass, based on the cut off of the local population.
Our Products and Services:
Intelligentization of medical diagnostic laboratories
It is a platform consisting of hardware and software for online management of equipment and utilities of medical diagnosis laboratories in order to monitor, record and control of electrical parameters as well as temperature and humidity of the environment and refrigerators with the aim of ensuring correct operation and protection of equipment and reducing energy consumption.
Newborn metabolic diseases screening test
This test is performed in order to screen 22 hereditary metabolic diseases, which are mainly caused by genetic defects in babies. It is conducted at the birth of the babies with only one sampling and using the advanced technique of LC Mass, based on the cut off of the local population.